Skip to content

Clinical trials

Phase 3 Digestive System Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Digestive System Diseases Phase: Phase 3 Country / region: United States Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20093
20101
20111
20123
20132
20142
20163
20172
20191
20203
20223
20243
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Active, not recruiting5
Terminated5
Recruiting4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bausch Health Americas, Inc.3
Gilead Sciences3
89bio, Inc.2
Ellodi Pharmaceuticals, LP2
M.D. Anderson Cancer Center2
Mirum Pharmaceuticals, Inc.2
Pfizer2
Sumitomo Pharma America, Inc.2
Zealand Pharma2
Abbott1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Digestive System Diseases30
Gastrointestinal Diseases14
Intestinal Diseases12
Liver Diseases9
Colonic Diseases8
Digestive System Neoplasms7
Gastroenteritis7
Pathologic Processes7
Neoplasms6
Neoplasms by Site6

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.